Drugs that reverse disease transcriptomic signatures are more effective in a mouse model of dyslipidemia

High-throughput omics have proven invaluable in studying human disease, and yet day-to-day clinical practice still relies on physiological, non-omic markers. The metabolic syndrome, for example, is diagnosed and monitored by blood and urine indices such as blood cholesterol levels. Nevertheless, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Wagner, Allon, Cohen, Noa, Kelder, Thomas, Amit, Uri, Liebman, Elad, Steinberg, David M, Radonjic, Marijana, Ruppin, Eytan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4380926/
https://www.ncbi.nlm.nih.gov/pubmed/26148350
http://dx.doi.org/10.15252/msb.20145486

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4380926/
https://www.ncbi.nlm.nih.gov/pubmed/26148350
http://dx.doi.org/10.15252/msb.20145486

Ejemplares similares